Monash IVF Group Limited (ASX:MVF)
0.6950
0.00 (0.00%)
Jun 5, 2026, 4:10 PM AEST
Monash IVF Group Market Cap
Monash IVF Group has a market cap or net worth of 270.8 million as of June 5, 2026. Its market cap has decreased by -9.15% in one year.
Market Cap
270.80M
Enterprise Value
464.39M
Revenue
269.39M
Ranking
n/a
PE Ratio
17.88
Stock Price
0.70
Market Cap Chart
Since June 26, 2014, Monash IVF Group's market cap has decreased from 534.53M to 270.80M, a decrease of -49.34%. That is a compound annual growth rate of -5.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 270.80M | -5.44% |
| Dec 31, 2025 | 286.38M | -42.13% |
| Dec 31, 2024 | 494.84M | -2.31% |
| Dec 29, 2023 | 506.53M | 36.13% |
| Dec 30, 2022 | 372.10M | -9.48% |
| Dec 31, 2021 | 411.06M | 34.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Integral Diagnostics | 756.15M |
| Australian Clinical Labs | 384.10M |
| Healius | 232.36M |
| Cryosite | 51.74M |
| INOVIQ | 47.86M |
| Microba Life Sciences | 38.36M |
| Rhythm Biosciences | 37.16M |
| BCAL Diagnostics | 27.28M |